Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
price fixing
Pharma
Sandoz ponies up $265M to settle lingering price-fixing case
Sandoz will shell out $265 million to settle long-running price fixing claims it inherited from its former parent Novartis.
Fraiser Kansteiner
Feb 29, 2024 10:49am
Apotex and 2 others settle in long-running price-fixing suit
Jan 24, 2024 2:19pm
Teva to cough up $225M to DOJ in price-fixing settlement
Aug 22, 2023 11:35am
Teva earmarks $200M for possible price-fixing settlement with US
Aug 2, 2023 2:49pm
Sun ready to complete Taro buyout—16 years after initial offer
May 30, 2023 10:48am
Sun, Eisai, AstraZeneca—Fierce Pharma Asia
Mar 17, 2023 8:00am